Membranous Nephropathy — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Membranous nephropathy
Subepithelial immune deposits causing GBM thickening on electron microscopy with positive anti-PLA2R antibodies is pathognomonic for primary membranous nephropathy. PLA2R is positive in ~70–80% of primary MN. Treatment of moderate-to-high-risk MN includes rituximab (increasingly first-line) or cyclophosphamide-based regimens plus supportive therapy (ACEi/ARB, statins).
Reference: eTG – 2025 – Nephrology; KDIGO – 2021 – Glomerular Diseases Guidelines